Immunological effects in patients with steroid-refractory graft-versus-host disease following treatment with basiliximab, a CD25 monoclonal antibody.
Eur J Haematol
; 97(2): 121-7, 2016 Aug.
Article
in En
| MEDLINE
| ID: mdl-26492560
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Recombinant Fusion Proteins
/
Graft vs Host Disease
/
Immunosuppressive Agents
/
Antibodies, Monoclonal
Type of study:
Diagnostic_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Eur J Haematol
Journal subject:
HEMATOLOGIA
Year:
2016
Document type:
Article
Affiliation country:
Germany
Country of publication:
United kingdom